LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 305

Search options

  1. Article ; Online: Emerging Roles of Gut Microbial Modulation of Bile Acid Composition in the Etiology of Cardiovascular Diseases.

    Yntema, Tess / Koonen, Debby P Y / Kuipers, Folkert

    Nutrients

    2023  Volume 15, Issue 8

    Abstract: Despite advances in preventive measures and treatment options, cardiovascular disease (CVD) remains the number one cause of death globally. Recent research has challenged the traditional risk factor profile and highlights the potential contribution of ... ...

    Abstract Despite advances in preventive measures and treatment options, cardiovascular disease (CVD) remains the number one cause of death globally. Recent research has challenged the traditional risk factor profile and highlights the potential contribution of non-traditional factors in CVD, such as the gut microbiota and its metabolites. Disturbances in the gut microbiota have been repeatedly associated with CVD, including atherosclerosis and hypertension. Mechanistic studies support a causal role of microbiota-derived metabolites in disease development, such as short-chain fatty acids, trimethylamine-N-oxide, and bile acids, with the latter being elaborately discussed in this review. Bile acids represent a class of cholesterol derivatives that is essential for intestinal absorption of lipids and fat-soluble vitamins, plays an important role in cholesterol turnover and, as more recently discovered, acts as a group of signaling molecules that exerts hormonal functions throughout the body. Studies have shown mediating roles of bile acids in the control of lipid metabolism, immunity, and heart function. Consequently, a picture has emerged of bile acids acting as integrators and modulators of cardiometabolic pathways, highlighting their potential as therapeutic targets in CVD. In this review, we provide an overview of alterations in the gut microbiota and bile acid metabolism found in CVD patients, describe the molecular mechanisms through which bile acids may modulate CVD risk, and discuss potential bile-acid-based treatment strategies in relation to CVD.
    MeSH term(s) Humans ; Cardiovascular Diseases/etiology ; Cardiovascular Diseases/metabolism ; Gastrointestinal Microbiome ; Bile Acids and Salts ; Hypertension/complications ; Cholesterol
    Chemical Substances Bile Acids and Salts ; Cholesterol (97C5T2UQ7J)
    Language English
    Publishing date 2023-04-12
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2518386-2
    ISSN 2072-6643 ; 2072-6643
    ISSN (online) 2072-6643
    ISSN 2072-6643
    DOI 10.3390/nu15081850
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Quantum Hair from Gravity.

    Calmet, Xavier / Casadio, Roberto / Hsu, Stephen D H / Kuipers, Folkert

    Physical review letters

    2022  Volume 128, Issue 11, Page(s) 111301

    Abstract: We explore the relationship between the quantum state of a compact matter source and of its asymptotic graviton field. For a matter source in an energy eigenstate, the graviton state is determined at leading order by the energy eigenvalue. Insofar as ... ...

    Abstract We explore the relationship between the quantum state of a compact matter source and of its asymptotic graviton field. For a matter source in an energy eigenstate, the graviton state is determined at leading order by the energy eigenvalue. Insofar as there are no accidental energy degeneracies there is a one to one map between graviton states on the boundary of spacetime and the matter source states. Effective field theory allows us to compute a purely quantum gravitational effect which causes the subleading asymptotic behavior of the graviton state to depend on the internal structure of the source. This establishes the existence of ubiquitous quantum hair due to gravitational effects.
    Language English
    Publishing date 2022-04-01
    Publishing country United States
    Document type Journal Article
    ZDB-ID 208853-8
    ISSN 1079-7114 ; 0031-9007
    ISSN (online) 1079-7114
    ISSN 0031-9007
    DOI 10.1103/PhysRevLett.128.111301
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Role of bile acids in inflammatory liver diseases.

    Evangelakos, Ioannis / Heeren, Joerg / Verkade, Esther / Kuipers, Folkert

    Seminars in immunopathology

    2021  Volume 43, Issue 4, Page(s) 577–590

    Abstract: Bile acids and their signaling pathways are increasingly recognized as potential therapeutic targets for cholestatic and metabolic liver diseases. This review summarizes new insights in bile acid physiology, focusing on regulatory roles of bile acids in ... ...

    Abstract Bile acids and their signaling pathways are increasingly recognized as potential therapeutic targets for cholestatic and metabolic liver diseases. This review summarizes new insights in bile acid physiology, focusing on regulatory roles of bile acids in the control of immune regulation and on effects of pharmacological modulators of bile acid signaling pathways in human liver disease. Recent mouse studies have highlighted the importance of the interactions between bile acids and gut microbiome. Interfering with microbiome composition may be beneficial for cholestatic and metabolic liver diseases by modulating formation of secondary bile acids, as different bile acid species have different signaling functions. Bile acid receptors such as FXR, VDR, and TGR5 are expressed in a variety of cells involved in innate as well as adaptive immunity, and specific microbial bile acid metabolites positively modulate immune responses of the host. Identification of Cyp2c70 as the enzyme responsible for the generation of hydrophilic mouse/rat-specific muricholic acids has allowed the generation of murine models with a human-like bile acid composition. These novel mouse models will aid to accelerate translational research on the (patho)physiological roles of bile acids in human liver diseases .
    MeSH term(s) Animals ; Bile Acids and Salts ; Gastrointestinal Microbiome ; Humans ; Liver ; Liver Diseases/etiology ; Mice ; Rats ; Signal Transduction
    Chemical Substances Bile Acids and Salts
    Language English
    Publishing date 2021-07-08
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2316828-6
    ISSN 1863-2300 ; 1863-2297
    ISSN (online) 1863-2300
    ISSN 1863-2297
    DOI 10.1007/s00281-021-00869-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Systems genetics approach reveals cross-talk between bile acids and intestinal microbes.

    Fu, Jingyuan / Kuipers, Folkert

    PLoS genetics

    2019  Volume 15, Issue 8, Page(s) e1008307

    MeSH term(s) Animals ; Bile ; Bile Acids and Salts ; Gastrointestinal Microbiome ; Intestines ; Mice
    Chemical Substances Bile Acids and Salts
    Language English
    Publishing date 2019-08-29
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 2186725-2
    ISSN 1553-7404 ; 1553-7390
    ISSN (online) 1553-7404
    ISSN 1553-7390
    DOI 10.1371/journal.pgen.1008307
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Quantitation of bioactive components in infant formulas: Milk oligosaccharides, sialic acids and corticosteroids.

    Liu, Fan / van der Molen, Jan / Kuipers, Folkert / van Leeuwen, Sander S

    Food research international (Ottawa, Ont.)

    2023  Volume 174, Issue Pt 1, Page(s) 113589

    Abstract: Human milk is considered the optimal food for infants with abundant nutrients and bioactive components, which play key roles in infant health and development. Infant formulas represent appropriate substitutes for human milk. There are many brands of ... ...

    Abstract Human milk is considered the optimal food for infants with abundant nutrients and bioactive components, which play key roles in infant health and development. Infant formulas represent appropriate substitutes for human milk. There are many brands of infant formula with different ingredient sources and functions on the market. The present study aims to quantify important bioactive components, i.e., milk oligosaccharides (MOS), sialic acids (Sia) and corticosteroids, in different infant formulas and compare these to human milk. In total, 12 different infant formulas available on the Dutch market were analyzed in this study. The concentrations of MOS and Sia were characterized by UHPLC-FLD and LC-MS, while corticosteroids were determined using established UHPLC-MS/MS methods. Among infant formulas, 15 structures of oligosaccharides were identified, of which 2'-Fucosyllactose (2'FL), 3'-Galactosyllactose (3'GL) and 6'-Galactosyllactose (6́'GL) were found in all infant formulas. The oligosaccharide concentrations differed between milk source and brands and were 3-5 times lower than in human milk. All infant formulas contained Sia, N-acetylneuraminic acid (Neu5Ac) was dominant in bovine milk-based formulas, while N-glycolylneuraminic acid (Neu5Gc) was major in goat milk-based formula. All infant formulas contained corticosteroids, yet, at lower concentrations than human milk. Insight in concentrations of bioactive components in infant formula compared to human milk may give direction to dietary advices and/or novel formula design.
    MeSH term(s) Infant ; Humans ; Infant Formula/chemistry ; Sialic Acids/analysis ; Tandem Mass Spectrometry ; Milk, Human/chemistry ; Oligosaccharides/analysis ; Adrenal Cortex Hormones/analysis
    Chemical Substances Sialic Acids ; Oligosaccharides ; Adrenal Cortex Hormones
    Language English
    Publishing date 2023-10-14
    Publishing country Canada
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1111695-x
    ISSN 1873-7145 ; 0963-9969
    ISSN (online) 1873-7145
    ISSN 0963-9969
    DOI 10.1016/j.foodres.2023.113589
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Characterization of milk oligosaccharide and sialic acid content and their influence on brain sialic acid in a lean mouse model for gestational diabetes.

    Liu, Fan / Tol, Angela J C / Kuipers, Folkert / Oosterveer, Maaike H / van der Beek, Eline M / van Leeuwen, Sander S

    Heliyon

    2024  Volume 10, Issue 3, Page(s) e24539

    Abstract: Oligosaccharides and sialic acids (Sia) are bioactive components in milk that contribute to newborn development and health. Hyperglycemia in pregnancy (HIP) can have adverse effects on both mother and infant. HIP is associated with low-grade systemic ... ...

    Abstract Oligosaccharides and sialic acids (Sia) are bioactive components in milk that contribute to newborn development and health. Hyperglycemia in pregnancy (HIP) can have adverse effects on both mother and infant. HIP is associated with low-grade systemic inflammation. Inflammation influenced glycan composition, particularly of Sia-containing structures. We hypothesize that HIP and high-fat diet influence milk oligosaccharide composition, particularly sialylated oligosaccharides. Furthermore, we propose that milk Sia content influences pup brain Sia content. To test these hypotheses we (i) characterize mouse milk oligosaccharides and Sia concentrations in mouse milk of a GDM mouse model with dietary fat intake intervention; and (ii) determine Sia levels in offspring brains. The concentrations of oligosaccharides and Sia in mouse milk and offspring's brains were quantified using UPLC-FLD analysis. Analyses were performed on surplus samples from a previous study, where HIP was induced by combining high-fat diet (HF) feeding and low-dose streptozotocin injections in C57Bl/6NTac female mice. The previous study described the metabolic effects of HIP on dams and offspring. We detected 21 mouse milk oligosaccharides, including 9 neutral and 12 acidic structures using UPLC-MS. A total of 8 structures could be quantified using UPLC-FLD. Maternal HIP and HF diet during lactation influenced sialylated oligosaccharide concentrations in mouse milk and total and free sialic acid concentrations. Sia content in offspring brain was associated with total and free Neu5Gc in mouse milk of dams, but no correlations with HIP or maternal diet were observed.
    Language English
    Publishing date 2024-01-24
    Publishing country England
    Document type Journal Article
    ZDB-ID 2835763-2
    ISSN 2405-8440
    ISSN 2405-8440
    DOI 10.1016/j.heliyon.2024.e24539
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Odevixibat Treatment Induces Biliary Bile Acid Secretion in Responsive Patients With Bile Salt Export Pump Deficiency.

    Nomden, Mark / Kuipers, Folkert / Hulscher, Jan B F / Lindström, Erik / Valcheva, Velichka / Verkade, Henkjan J

    Gastroenterology

    2023  Volume 165, Issue 2, Page(s) 496–498.e1

    MeSH term(s) Humans ; ATP Binding Cassette Transporter, Subfamily B, Member 11 ; Liver ; Bile ; Bile Acids and Salts
    Chemical Substances ATP Binding Cassette Transporter, Subfamily B, Member 11 ; odevixibat (2W150K0UUC) ; Bile Acids and Salts
    Language English
    Publishing date 2023-03-31
    Publishing country United States
    Document type Journal Article
    ZDB-ID 80112-4
    ISSN 1528-0012 ; 0016-5085
    ISSN (online) 1528-0012
    ISSN 0016-5085
    DOI 10.1053/j.gastro.2023.03.226
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Emerging roles of bile acids in control of intestinal functions.

    Yang, Jiufang / Palmiotti, Anna / Kuipers, Folkert

    Current opinion in clinical nutrition and metabolic care

    2020  Volume 24, Issue 2, Page(s) 127–133

    Abstract: Purpose of review: Bile acids and their signalling pathways are increasingly recognized as potential therapeutic targets for several diseases. This review summarizes new insights in bile acid physiology, focussing on regulatory roles of bile acids in ... ...

    Abstract Purpose of review: Bile acids and their signalling pathways are increasingly recognized as potential therapeutic targets for several diseases. This review summarizes new insights in bile acid physiology, focussing on regulatory roles of bile acids in intestinal functions.
    Recent findings: Recent studies have highlighted the interactions between bile acids and gut microbiome: interfering with microbiome composition may be beneficial in treatment of liver and metabolic diseases by modulating bile acid composition, as different bile acid species have different signalling functions. In the intestine, bile acid receptors FXR, VDR and TGR5 are involved in control of barrier function, paracellular ion transport and hormone release. Specific microbial bile acid metabolites modulate immune responses of the host. In addition, new functions of bile acids in regulation of gastric emptying and satiation via brain-gut-liver axis have been discovered. Identification of Cyp2c70 as the enzyme responsible for generation of hydrophilic mouse/rat-specific muricholic acids has allowed the generation of murine models with a human-like bile acid composition.
    Summary: Specific bile acids act as important signalling molecules affecting whole body metabolism, specific transport processes and immunity in different segments of the intestinal tract. Their relevance for human (patho)physiology is emerging. Novel mouse models with human-like bile acid composition will aid to accelerate translational research.
    MeSH term(s) Animals ; Bile Acids and Salts ; Disease Models, Animal ; Gastrointestinal Microbiome ; Humans ; Liver ; Mice ; Rats ; Signal Transduction
    Chemical Substances Bile Acids and Salts
    Language English
    Publishing date 2020-10-19
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 1460178-3
    ISSN 1473-6519 ; 1363-1950
    ISSN (online) 1473-6519
    ISSN 1363-1950
    DOI 10.1097/MCO.0000000000000709
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Microbiome Modulation of the Host Adaptive Immunity through Bile Acid Modification.

    Kuipers, Folkert / de Boer, Jan Freark / Staels, Bart

    Cell metabolism

    2020  Volume 31, Issue 3, Page(s) 445–447

    Abstract: The microbiome is well known to influence the immune response of the host. Song et al. now show that the microbiome modulates adaptive immunity in mice through formation of bile acid species acting on ... ...

    Abstract The microbiome is well known to influence the immune response of the host. Song et al. now show that the microbiome modulates adaptive immunity in mice through formation of bile acid species acting on RORγ
    MeSH term(s) Adaptive Immunity ; Animals ; Bile ; Gastrointestinal Microbiome ; Homeostasis ; Mice ; Microbiota ; Nuclear Receptor Subfamily 1, Group F, Member 3 ; T-Lymphocytes, Regulatory
    Chemical Substances Nuclear Receptor Subfamily 1, Group F, Member 3
    Language English
    Publishing date 2020-03-02
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Comment
    ZDB-ID 2176834-1
    ISSN 1932-7420 ; 1550-4131
    ISSN (online) 1932-7420
    ISSN 1550-4131
    DOI 10.1016/j.cmet.2020.02.006
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Modulation of Bile Acid Metabolism to Improve Plasma Lipid and Lipoprotein Profiles.

    Zhang, Boyan / Kuipers, Folkert / de Boer, Jan Freark / Kuivenhoven, Jan Albert

    Journal of clinical medicine

    2021  Volume 11, Issue 1

    Abstract: New drugs targeting bile acid metabolism are currently being evaluated in clinical studies for their potential to treat cholestatic liver diseases, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Changes in bile acid ... ...

    Abstract New drugs targeting bile acid metabolism are currently being evaluated in clinical studies for their potential to treat cholestatic liver diseases, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Changes in bile acid metabolism, however, translate into an alteration of plasma cholesterol and triglyceride concentrations, which may also affect cardiovascular outcomes in such patients. This review attempts to gain insight into this matter and improve our understanding of the interactions between bile acid and lipid metabolism. Bile acid sequestrants (BAS), which bind bile acids in the intestine and promote their faecal excretion, have long been used in the clinic to reduce LDL cholesterol and, thereby, atherosclerotic cardiovascular disease (ASCVD) risk. However, BAS modestly but consistently increase plasma triglycerides, which is considered a causal risk factor for ASCVD. Like BAS, inhibitors of the apical sodium-dependent bile acid transporter (ASBTi's) reduce intestinal bile acid absorption. ASBTi's show effects that are quite similar to those obtained with BAS, which is anticipated when considering that accelerated faecal loss of bile acids is compensated by an increased hepatic synthesis of bile acids from cholesterol. Oppositely, treatment with farnesoid X receptor agonists, resulting in inhibition of bile acid synthesis, appears to be associated with increased LDL cholesterol. In conclusion, the increasing efforts to employ drugs that intervene in bile acid metabolism and signalling pathways for the treatment of metabolic diseases such as NAFLD warrants reinforcing interactions between the bile acid and lipid and lipoprotein research fields. This review may be considered as the first step in this process.
    Language English
    Publishing date 2021-12-21
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm11010004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top